You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
均瑤健康(605388.SH)半年度淨利潤預降61.01%-64.73% 原材料持續上漲、成本端負擔大幅上升
格隆匯 07-12 16:11

格隆匯7月12日丨均瑤健康(605388.SH)公佈2022年半年度業績預吿,公司預計2022年半年度實現歸屬於上市公司股東的淨利潤為4391.33萬元到4853.57萬元,與上年同期(法定披露數據)相比,將減少7595.56到8057.80萬元,同比下降61.01%到64.73%;預計2022年半年度實現歸屬於上市公司股東的扣除非經常性損益的淨利潤為2791.27萬元到3085.09萬元,與上年同期(法定披露數據)相比,將減少5805.42到6099.24萬元,同比下降65.30%到68.60%。

本期業績預減的主要原因:

(一)報吿期內,受國際環境影響,公司使用的主要原材料發生較大幅度地持續上漲,疊加製造成本等諸多因素的影響,對比上年同期成本端負擔大幅上升,導致公司2022年上半年經營業績同比產生較大幅度波動,影響業績表現。未來公司將會採取有效手段予以積極應對。

(二)受國內新冠疫情影響,報吿期內部分子公司停產、物流不暢等因素導致公司生產、發貨、銷售等多環節均受到不同程度地影響。隨着疫情逐漸平復,公司已經採取多種措施最大程度地保證公司經營活動的正常開展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account